Visual acuity ≥ 5/200 at 3 years · surgery for retinal detachment associated with proliferative vitreoretinopathy
Silicone oil showed no clear difference in visual acuity ≥ 5/200 at 3 years compared with perfluropropane (C3F8) (low certainty).
1 finding from 1 review
Macular attachment at 18 months · surgery for retinal detachment associated with proliferative vitreoretinopathy
Silicone oil showed no clear difference in macular attachment at 3 years compared with perfluropropane (C3F8) (low certainty).
1 finding from 1 review
Visual improvement at end of treatment, as defined by two or more Snellen lines · people with diabetic retinopathy
Single herb plus conventional intervention may leads to higher visual acuity (gain of ≥ 2 lines) (end of treatment) compared with conventional intervention (low certainty).
1 finding from 1 review
Reduction in microaneurysms · people with diabetic retinopathy
It is very uncertain whether single herb plus conventional intervention changes reduction in microaneurysms compared with conventional intervention (very low certainty).
1 finding from 1 review
Observations in retina: reduction in haemorrhages · people with diabetic retinopathy
It is very uncertain whether single herb plus conventional intervention changes observations in retina: reduction in haemorrhages compared with conventional intervention (very low certainty).
1 finding from 1 review
HbA1c (%) · people with diabetic retinopathy
1 finding from 1 review
Adverse outcomes · people with diabetic retinopathy
1 finding from 1 review
Proportion of participants attending screening (median · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Ongoing adherence to screening · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic Outcomes Resources used (staff time, equipment, consumables) · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Staff/personnel costs; costs of treatment and care; cost of primary care; lost wages and lost productivity · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Incremental cost‐effectiveness · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Proportion of participants attending screening (median · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
1 finding from 1 review
Ongoing adherence to screening · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Economic outcomes · patients with type 1 or 2 diabetes eligible for diabetic retinopathy screening
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BCVA: loss of 15 or more ETDRS letters · proliferative diabetic retinopathy
It is very uncertain whether nd:YAG laser changes BCVA: loss of 15 or more ETDRS letters compared with argon‐green laser (very low certainty).
1 finding from 1 review
Progression of PDR · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes progression of PDR compared with argon laser (very low certainty).
1 finding from 1 review
Regression of PDR · proliferative diabetic retinopathy
It is very uncertain whether diode laser changes regression of PDR compared with argon laser (very low certainty).
1 finding from 1 review
Pain during laser treatment ‐ not reported · proliferative diabetic retinopathy
Diode laser probably leads to higher pain during laser treatment compared with argon laser (moderate certainty).
1 finding from 1 review
Vision‐related QoL ‐ not reported · proliferative diabetic retinopathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found